Genomics Going from a Passive to an Active Science: John Stuelpnagel on the “Write” Revolution
“I think the next level of biological discovery is going to be where you can actively perturb the system — it’s called...
Read More
Biology Driving Big Changes to Global Economy
Kevin Ness, CEO at Inscripta, on human genomics and the business of gene editing. Hosted by Carol Massar and Jason...
Read More
Top 10 Companies Leveraging Gene Editing in 2019
In June at the 2019 Synthetic Biology: Engineering, Evolution & Design (SEED) conference in New York City, Inscripta publicly presented...
Read More
Single Cell Writing May Unlock CRISPR’s Full Potential
After over three years of super stealth mode, Inscripta gave its first public presentation today at the 2019 Synthetic Biology:...
Read More
Inscripta®’s MAD7™ Named a Top Innovation of 2018 by The Scientist
The award recognizes products that are set to revolutionize research and advance scientific knowledge
Read More
- 1
- 2